Crossmark

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate

Crossref DOI link: https://doi.org/10.1186/s13014-019-1267-3

Published Online: 2019-04-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Trinh, Vincent Q.

Benzerdjeb, Nazim

Chagnon-Monarque, Ségolène

Dionne, Nicolas

Delouya, Guila

Kougioumoutzakis, André

Sirois, Jennifer

Albadine, Roula

Latour, Mathieu

Mes-Masson, Anne-Marie

Hovington, Hélène

Bergeron, Alain

Zorn, Kevin C.

Fradet, Yves

Saad, Fred

Taussky, Daniel

Trudel, Dominique
Funding

Funding for this research was provided by:

Fonds de Recherche du Québec - Santé

Canadian Cancer Society

Institut du Cancer de Montréal

Prostate Cancer Canada
License Information

Text and Data Mining valid from 2019-04-25
More Information

Article History

Received: 12 November 2018

Accepted: 28 March 2019

First Online: 25 April 2019

Ethics approval and consent to participate

: Ethics committee approval and consent to participate were obtained.

: All authors approved the manuscript for publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.